BIT
ENTA icon

BlackRock Institutional Trust’s Enanta Pharmaceuticals ENTA Stock Holding History

BlackRock Institutional Trust’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$15.4M Buy
459,134
+68,446
+18% +$1.96M ﹤0.01% 2150
2016
Q3 		$10.4M Buy
390,688
+14,440
+4% +$335K ﹤0.01% 2311
2016
Q2 		$8.3M Buy
376,248
+2,052
+0.5% +$53.7K ﹤0.01% 2402
2016
Q1 		$11M Sell
374,196
-120
-0% -$3.34K ﹤0.01% 2202
2015
Q4 		$12.4M Sell
374,316
-21,267
-5% -$693K ﹤0.01% 2193
2015
Q3 		$14.3M Buy
395,583
+40,692
+11% +$1.75M ﹤0.01% 2070
2015
Q2 		$16M Buy
354,891
+30,246
+9% +$1.18M ﹤0.01% 2079
2015
Q1 		$9.94M Buy
324,645
+155,786
+92% +$6.06M ﹤0.01% 2393
2014
Q4 		$8.59M Buy
168,859
+16,309
+11% +$730K ﹤0.01% 2449
2014
Q3 		$6.04M Buy
152,550
+36,386
+31% +$1.45M ﹤0.01% 2604
2014
Q2 		$5M Buy
116,164
+75,915
+189% +$2.9M ﹤0.01% 2792
2014
Q1 		$1.61M Sell
40,249
-12,742
-24% -$463K ﹤0.01% 3258
2013
Q4 		$1.45M Sell
52,991
-28,935
-35% -$701K ﹤0.01% 3275
2013
Q3 		$1.88M Sell
81,926
-101,707
-55% -$1.94M ﹤0.01% 3156
2013
Q2 		$3.25M Buy
+183,633
New +$3.58M ﹤0.01% 2883

Other funds holding ENTA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock Institutional Trust's ENTA Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Enanta Pharmaceuticals (ENTA) stake by 18% in Q4 2016, buying an estimated $1.96M and bringing the position to 459,134 shares worth $15.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2150.

BlackRock Institutional Trust first reported a position in ENTA in Q2 2013 and has held it in 15 quarters since. The position peaked at $16M in Q2 2015. 149 funds tracked by Wall St. Rank hold ENTA as of Q4 2016.

  • BlackRock Institutional Trust held 459,134 shares of Enanta Pharmaceuticals worth $15.4M as of Q4 2016.
  • BlackRock Institutional Trust bought 68,446 Enanta Pharmaceuticals shares in Q4 2016, an estimated $1.96M.
  • Enanta Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2150 holding.
  • BlackRock Institutional Trust first reported a position in Enanta Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Enanta Pharmaceuticals position peaked at $16M in Q2 2015.
  • 149 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.